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innate immune system is the first to respond to the infection, with type I interferons (IFNs), inflammatory
cytokines, killing of infected host cells, and priming of a balanced adaptive immune response. The virus
possesses a variety of immune evasion strategies, including inhibition of type I IFN production, chemokine
and complement binding, infection of macrophages and neutrophils, and latency. BHV-1 immune
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Abstract
Bovine herpesvirus 1 (BHV-1) causes a variety of diseases and is globally distributed. It infects
via mucosal epithelium, leading to rapid lytic replication and latent infection, primarily in
sensory ganglia. Large amounts of virus can be excreted by the host on primary infection or
upon recrudescence of latent infection, resulting in disease spread. The bovine immune
response to BHV-1 is rapid, robust, balanced, and long-lasting. The innate immune system is
the first to respond to the infection, with type I interferons (IFNs), inflammatory cytokines,
killing of infected host cells, and priming of a balanced adaptive immune response. The virus
possesses a variety of immune evasion strategies, including inhibition of type I IFN production,
chemokine and complement binding, infection of macrophages and neutrophils, and latency.
BHV-1 immune suppression contributes to the severity of its disease manifestations and to the
bovine respiratory disease complex, the leading cause of cattle death loss in the USA.
Keywords: bovine herpesvirus 1 (BHV-1), bovine respiratory disease complex (BRDC),
latency, innate immunity, pathogen recognition receptor (PRR), immune evasion
1. Introduction
Bovine herpesvirus 1 (BHV-1) causes a variety of diseases
(Gibbs and Rweyemamu, 1977) and infection is world-
wide (Beer, 2012). The diseases it causes are costly both
in direct disease effects and in lost trade. Immunosup-
pression by BHV-1 potentiates secondary infections, and
it is a major component of the bovine respiratory disease
complex (BRDC), which has a large economic impact on
the cattle industry in the USA (Jones and Chowdhury,
2007; Anon, 2011).
BHV-1 has been found to infect a number of artiodactyl
species, and is closely related to viruses infecting other
domestic and wild ungulates (Thiry et al., 2006). It is
considered the prototype herpesvirus species of rumi-
nants (Robinson et al., 2008). BHV-1 is also similar to the
(human) type species of its genus (Varicellovirus),
subfamily (Alphaherpesvirinae, aHV), and family
(Herpesviridae, HV) and demonstrates similar life-cycle
events. The human HV viruses, and the aHV viruses of
veterinary importance such as BHV-1, have been exten-
sively studied.
Although similar in many respects to the human
immune response to human herpesvirus 1 (HHV-1), the
differences in the bovine immune system, physiology,
lifestyle and BHV-1 proteins mean the bovine immune
response to BHV-1 is unique. The impact of the diseases
caused by BHV1, and the promise of their mitigation by
immunologic means, make understanding BHV1 infection
and the bovine immune response to it important and
relevant.
2. BHV-1 life-cycle
2.1. Classification
BHV-1 is a member of the HV family, whose type species
is HHV-1, also known as herpes simplex virus 1 (HSV-1).*Corresponding author. E-mail: Randall.L.Levings@aphis.usda.gov
*c Cambridge University Press 2013 This is a work of the U.S. Government and is not
subject to copyright protection in the United States.
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Membership in the family is based on virion architecture:
a core containing a linear double-stranded (ds) DNA
genome, an 100 nm icosahedral capsid of 162
capsomers, an amorphous tegument, and an envelope
containing viral glycoprotein (GP) spikes (Pellett and
Roizman, 2007). HV specify a large number of enzymes
for DNA synthesis, processing of proteins, and other
functions. The genome synthesis and capsid assembly
occurs in the host cell nucleus. Production of infectious
progeny results in the destruction of the host cell. All HV
are able to remain latent in their hosts (Pellett and
Roizman, 2007).
BHV-1 is a member of the aHV sub-family, whose
type species is HHV-1. Members of this subfamily are
classified based on variable host range, short reproductive
cycle, lytic infection of cells, and ability to establish
latency primarily in sensory ganglia (Pellett and Roizman,
2007). The aHV include numerous viruses of veterinary
importance, including the varicelloviruses noted below
and gallid herpesvirus 1 (infectious laryngotracheitis
virus) and gallid herpesvirus 2 (Marek’s disease virus).
Such viruses may be studied as aHV models and for
disease control purposes (Mettenleiter, 1996; Pomeranz
et al., 2005).
BHV-1 is a member of the genus Varicellovirus, whose
type species is human herpesvirus 3 (HHV-3), also known
as varicella-zoster virus (VZV). Membership in the genus
is based on wide tissue tropism and genome arrangement
(Cohen et al., 2007). The varicelloviruses include suid
herpesvirus 1 (SHV-1, pseudorabies virus, or PRV), equid
herpesvirus 1 (EHV-1, equine abortion virus), equid
herpesvirus 4 (EHV-4, equine rhinopneumonitis virus),
and felid herpesvirus 1 (FHV-1, feline viral rhinotracheitis,
or FVR) (Davison, 2010).
Isolation of BHV-1 was first reported in the USA in
1956 (Madin et al., 1956). Subtypes 1.1, 1.2a, and 1.2b,
formerly including 1.3a and 1.3b that are now a separate
species (BHV-5), were identified by genetic and antigenic
analysis (Engels et al., 1981; Misra et al., 1983; Brake and
Studdert, 1985; Metzler et al., 1985; Wyler et al., 1989) and
were associated with geographic range and prevalence of
clinical manifestations (Edwards et al., 1990; van Oirschot
et al., 1995; D’Arce et al., 2002).
2.2. Virion structure
2.2.1. Genome
There are six sequence arrangements of the dsDNA
genomes of HV, based on the presence and location of
repeats of terminal sequences. BHV-1 takes the D form, in
which the terminal sequence is repeated in an inverted
orientation internally. The genome segment between the
repeats (unique short, or US) exists in two orientations
relative to the unique long (UL) segment (Pellett and
Roizman, 2007).
The genome of BHV-1 was first mapped by
Mayfield et al. (1983), and later sequenced by an
international consortium (Schwyzer and Ackermann,
1996). The genome maps of BHV-1.1 and 1.2 (Mayfield
et al., 1983) and BHV-5 (Engels et al., 1986) were
determined and percent identity of BHV-1.1 to BHV-1.2
(95%) and BHV-1.1 to BHV5 (85%) calculated.
Seventy-three open reading frames (ORFs) were
identified in the 135,301 base pair (bp) genome (Glazov
et al., 2010). Genes of HV overlap, and are not spliced
(Pellett and Roizman, 2007). Of the 73 genes, 33 were
found to be essential to in vitro replication, 36 were not
essential, with the status of 2 dual-copy genes incon-
clusive (Robinson et al., 2008). Most, but not all, of the
genes of BHV-1 conform to HHV-1 homologs in location,
sequence (Whitbeck et al., 1994) and replication require-
ments (Robinson et al., 2008). Of the 71 BHV-1 proteins,
67 are conserved in each of HHV3 and HHV-1 (Davison,
2010). Eight of 73 genes (spread among regulatory,
capsid, tegument, and membrane proteins) differed
from HHV-1 in their requirement for in vitro replication
(Robinson et al., 2008). Four ORFs are unique to
BHV-1: Circ; UL0.5; UL3.5; and US1.5 (Schwyzer and
Ackermann, 1996). Some genes are conserved across all
HVs, including those that encode DNA polymerase, major
capsid protein UL19 [virus protein (VP) 5], tegument
protein UL7, and some envelope GPs such as gB. Others
are conserved at the subfamily level; for aHVs, examples
include latency-associated genes and gL (Pellett and
Roizman, 2007; Davison, 2010). Genes and products of
various HVs were named for positions of their restriction
endonuclease fragments on gels, gene position on
mapped genomes, sequence of expression or identifica-
tion, and HHV-1 homolog. This can be particularly
confusing when the genome position in a virus is not
the same as the ‘genome position name’ of the HHV-1
homolog.
Host RNA polymerase II is responsible for viral DNA
transcription (Roizman et al., 2007). Viral gene transcrip-
tion is temporally regulated, in immediate early (IE, or a),
early (E, or b), early/late (leaky late, g 1), and true late
(g 2) phases (Seal et al., 1992; Roizman et al., 2007).
IE genes are defined as those transcribed in the
absence of de novo viral protein synthesis. In HHV-1, IE
transcription is induced by the tegument protein atrans-
inducing factor (TIF) (VP 16), occurs in the first 2–4 h
after infection, and includes transcripts for six proteins
(Roizman et al., 2005). Several of these encode regulatory
proteins that stimulate expression of E and late (L) genes
(Smiley, 2004), and one [infected cell protein (ICP) 0] is
involved in blocking host cell silencing by the nuclear
domain ten protein of promyelocytic leukemia (PML)
nuclear bodies (Tavalai and Stamminger, 2009).
In BHV-1, a-TIF also stimulates IE gene transcription
by a different mechanism (Misra et al., 1995). BHV-1 IE
transcription units 1 and 2 (IEtu1 and 2) encode
homologs of HHV-1 ICP0 and ICP4, plus Circ and ICP22,
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respectively (Jones and Chowdhury, 2007). bICP0 is a
transactivator for all viral promoters and the bICP0
transcript is constitutively expressed during productive
infection (Jones and Chowdhury, 2007). bICP0 apparently
does not bind to specific DNA sequences, suggesting that
it activates by interacting with cellular transcriptional
machinery (Jones and Chowdhury, 2007). bICP0, 4, and
22 activate E genes.
E (or b) gene transcription occurs 4–8 h after HHV-1
infection. b gene proteins include enzymes and DNA-
binding proteins involved in DNA replication. g 1 genes
are only moderately stimulated by DNA replication, and
they can be difficult to differentiate from b and from g 2
genes. gB and gD genes are g 1 in HHV-1 (Roizman et al.,
2007), but in BHV-1 the proteins are produced as early
as 2–4 h after infection (before DNA replication)
(Baranowski et al., 1996). g 2 genes are defined as having
almost no production without DNA replication, and are
largely involved in virion assembly. gC is a g 2 protein.
Most capsid, tegument, and envelope GPs are encoded by
g genes.
In addition to the ORFs identified in the BHV-1
genome, ten micro RNA (miRNA) genes have been
identified, encoding 12 mature miRNAs with 14 miRNA-
encoding loci. Two are located close to the origin of
replication.
2.2.2. Core
For HHV-1, there is no specific protein coating the DNA in
the core. There are polyamines, which are suggested to
neutralize the DNA for better packing within the capsid
(Roizman et al., 2005).
2.2.3. Capsid
The capsid of HHV-1 is made up of 162 capsomers
with T=16 icosahedral symmetry. The capsid is composed
of an outer layer and an intermediate shell, with potential
channels between the core and outside of capsid. The
outer shell is composed of four proteins. VP5 is the
major capsid protein, with five copies in each penton
capsomere and six in each hexon capsomere (Roizman
et al., 2007). VP5 is conserved across aHV (Davison,
2010) and BHV-1 VP5 is an essential gene (Robinson
et al., 2008).
2.2.4. Tegument
The space between the envelope and the surface of the
capsid is mostly unstructured in HHV-1, but contains a
variety of viral proteins (Roizman et al., 2007) differen-
tially located in an inner and outer layer. They play a wide
variety of roles, from capsid transport during entry
and egress to regulation of transcription, translation, and
apoptosis (Kelly et al., 2009). In BHV-1, the tegument
protein VP8 (UL47) is the most abundant protein in the
virion (Carpenter and Misra, 1991) and appears to act as
an RNA-transporting protein (Verhagen et al., 2006). VP22
of BHV-1 is similar to that of HHV-1, but has some
differences in cellular localization (Harms et al., 2000;
Zheng et al., 2005). VP22 activities include microtubule
reorganization and intracellular trafficking. UL41 encodes
the viral host shutdown (VHS) protein of BHV-1 – it is
conserved in aHVs (Muylkens et al., 2007). In other aHVs
studied, VHS is an mRNA-specific RNase that triggers
rapid shutoff of host cell protein synthesis (Smiley, 2004).
It degrades both viral and host mRNA, but the viral mRNA
continues to accumulate (Roizman and Taddeo, 2007).
The tegument also contains cellular and viral transcripts
(Roizman et al., 2007), as well as non-coding RNA (Amen
and Griffiths, 2011). The RNA may be structural, or may
code for an immunoregulatory protein as is known for
HHV8. miRNAs are also known to be packaged in the
virion (Amen and Griffiths, 2011).
2.2.5. Envelope
The aHV envelope consists of a lipid bilayer acquired
from host cellular membrane, with virus-encoded
proteins imbedded in it (Roizman et al., 2007). Twelve
envelope proteins have been described for BHV-1, ten of
which are glycosylated, whereas two are not (gN or
UL49.5 and US9) (Jones and Chowdhury, 2007). The ten
GPs are named gB, gC, gD, gE, gG, gH, gI, gK, gL, and gM
(Turin et al., 1999). gB, gC, and gD are considered ‘major’
or more abundant GPs, and others (e.g. gE and gH) as
‘minor’ GPs (Baranowski et al., 1996). Most GPs are
homologous in function and structure to those specified
by HHVI but there are clear differences in sequences and
roles (Turin et al., 1999).
There are striking differences between the varicello-
viruses HHV-3 and BHV-1; gE is essential in HHV3, but
not in BHV-1, and gD is essential in BHV-1, but not
present in VZV (Robinson et al., 2008; Davison, 2010).
The gN of HHV-1 and SHV1 is glycosylated, whereas
UL49.5 is a ‘false GP’ in BHV-1 (Muylkens et al., 2007). GP
complexes of BHV-1 were variously named by their
positions in polyacrylamide gels, by their molecular
weights, by apparent homology with the GPs of other
HV including HHV-1, and finally in accordance with
the homologous HHV-1 GPs. The three major BHV-1
GPs can serve as examples: gB (named GVP 6/11a/
16, 130 K/74 K/55 K, gI, and gB); gC (named GVP 3/9,
180 K/91 K, gIII, and gC); and gD (named GVP 11b,
150 K/77 K, gIV, and gD).
Five envelope GPs are involved in HHV-1 attachment
and entry, as well as fusion of infected cells: gB, gC, gD,
gH, and gL (Spear et al., 2000; Rey, 2006). It is believed
similar mechanisms apply to all aHV except those lacking
gD, e.g. HHV3. The homodimer gC first binds non-
specifically, possibly electrostatically (Cohen et al., 2007)
to the host cell membrane glycosaminoglycans. Binding
by other GPs (e.g. gB non-specifically to those same
receptors, or gD specifically to its receptors) can
contribute to binding, and gC is not required for
attachment. This is followed by the homodimer gD
binding to one of the three cellular receptors that vary
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by cell type and species, although they are usually
homologous (Connolly et al., 2001). The three types of
receptors are: herpesvirus entry mediator (HVEM) A;
members of the nectin family; and 3-O-sulfated heparin
sulfate. The use of receptors is specific for each of the
closely related aHV studied (HHV-1, HHV-2, SHV-1, and
BHV-1) (Campadelli-Fiume et al., 2000; Spear, 2004). The
use of multiple receptors by any one aHV may be due to
the receptors’ presence and absence on various cell types
(e.g. epithelium versus T cells) and their presence on
various cell surfaces (e.g. apical for primary infection,
tight junctions for cell-to-cell spread) (Spear, 2004).
In describing fusion of the viral envelope with the
cell membrane, the differences in gB and gD among
the aHV make comparisons difficult. It seems all HVs
require gB and gH/gL for entry and cell–cell fusion, and
some (including HHV-1 and BHV-1) also require gD
(Spear et al., 2006; Atanasiu et al., 2010). gD of HHV-1
has a receptor binding face and a fusion activation face.
The nectin-1 and HVEM binding sites are distinct, and
the amino- and carboxyl-terminal peptides of gD play a
role in covering or revealing binding sites (Di Giovine
et al., 2011). gD assumes a different conformation in
the absence of receptor, bound to HVEM, and bound
to nectin-1 (Spear et al., 2006). It is believed that
gD-receptor binding results in a displacement of the
gD C-terminal region, triggering virus envelope – cell
membrane fusion by gB or gH/L (Krummenacher et al.,
2005).
‘Lead roles’ in fusion have been assigned to each of gB
and gH. gB is a homotrimer with fusion domains similar
to the vesicular stomatitis virus fusion GP (Heldwein
et al., 2006). Homologs within the HV are highly
conserved. A furin protease site is present on almost all
gB homologs (including BHV-1 gB), but not on HHV-1.
Since gH/gL did not resemble any documented viral
fusion protein at a structural level, Atanasiu et al., (2010)
proposed that receptor-activated gD alters gH/gL, which
in turn up-regulates the fusogenic potential of gB.
Conversely, Roizman et al., (2007) proposed fusion is
due to a fusion peptide (Tu and Kim, 2008) and heptad
repeats of gH, possibly activated by gB and conforma-
tionally altered gD. In this model, gL may block exposure
of the repeats if not activated.
2.3. Virus entry into the host
The ‘portals of entry’ for BHV-1 are the mucous
membranes of the upper respiratory tract, the genital
tract, or the conjunctiva (Muylkens et al., 2007). Direct
nose-to-nose contact or aerosol over short distances
can result in infection (Mars et al., 1999, 2000). Genital
infection can result from mating, or via infected semen
(Muylkens et al., 2007). It has been proposed that the first
cells infected with HHV3 are the epithelium and T cells
(Abendroth et al., 2010; Arvin et al., 2010).
Although BHV-1 subtypes were associated with differ-
ent routes of infection, this may have been due to
geographical isolation and common transmission. Each
subtype will infect by the less-common route (Muylkens
et al., 2007), and no difference in tropism was found
using ovine respiratory and genital mucosal explants
(Steukers et al., 2011). However, it should be noted that
an anti-gC monoclonal antibody (MAb) was described
that failed to react with all BHV1 genital isolates tested
(Rijsewijk et al., 1999), and gC differences in HHV-1 and
2 do influence cell tropism properties (Muylkens et al.,
2007).
2.4. Dissemination in the host
Intracellular BHV-1 virions were detected at 10 h post-
infection, with transmission to adjacent cells occurring at
that time (Babiuk et al., 1975). gE (Rebordosa et al., 1996),
gI, and gG are important to cell-to-cell spread of HHV-1.
gD, gB, and gH/L are required for cell-to-cell spread by
BHV-1, with contributions from gE and gG (Trapp et al.,
2003; Muylkens et al., 2007). It has been noted that
microvesicles secreted by HHV-1-infected cells (light [L]-
bodies) contain tegument proteins that can prepare cells
for infection (Meckes and Raab-Traub, 2011).
Extracellular BHV-1 virions were detected at 12–13 h
post-infection (Babiuk et al., 1975), which would allow
infection of adjacent and non-adjacent cells. The virus
may spread by viremia, leading to, e.g. abortion or
systemic disease. Viremia may be cell-free (Kaashoek
et al., 1996) but is more likely via infected lymphocytes
(LC) (Nandi et al., 2009).
2.5. Latency
Neurons of the peripheral nervous system are infected
by cell-to-cell spread (Jones and Chowdhury, 2007). In a
BHV-1 respiratory infection, this involves the trigeminal
ganglia (TG), usually only first-order neurons. BHV-1
does not invade the central nervous system via the
olfactory pathway as BHV5 does, due to differences in gE
(Al-Mubarak et al., 2004; Chowdhury et al., 2006). High
levels of virus gene expression and infectious virus are
detected in the TG 1–6 days after infection (Jones and
Chowdhury, 2007). Then lytic gene expression and
infectious virus levels drop, but viral genomes can be
detected, and latency-related (LR) and ORF-E transcripts
are produced at high levels. LR transcripts are detected
early after neuron infection (Devireddy and Jones, 1999)
and may have a role in determining the outcome of
neuronal infection (Jones and Chowdhury, 2007).
BHV-1 LR gene products inhibit cell proliferation,
bICP0 RNA expression, and apoptosis (Lovato et al.,
2003; Jones et al., 2006). BHV-1 LR protein appears to
prevent cell cycle progression in neurons, with enhanced
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survival of infected neurons (Schang et al., 1996). The LR
gene is antisense to bICP0, which is a transactivator for all
viral promoters. Expression of the BHV-1 LR gene alone
promotes survival in cell cultures stimulated to enter
programmed cell death (Ciacci-Zanella et al., 1999). The
LR gene contains two ORFs, and the LR RNA is
alternatively spliced in TG at day 7 (the transition to
latency). The alternate transcript codes for a fusion of one
ORF and part of the other, and the resulting protein binds
two host cell proteins that can induce apoptosis,
including BH3-interacting domain death agonist (Bid). It
also binds an ‘enhancer-binding protein’ (C/EBP-a),
which stimulates lytic gene transcription in other HVs.
ORF-E is a small ORF within the LR promoter (and
antisense to LR), which may maintain neuron function
after infection (Jones and Chowdhury, 2007).
In HHV-1, miRNAs are expressed during latency that
target ICP0 and ICP4, lytic genes (Boss and Renne, 2010).
One of the 12 mature miRNAs encoded in BHV-1 is
antisense to the LR gene (Glazov et al., 2010).
BHV-1 latency may also be established in cells of
lymphoid origin. BHV-1 DNA has been detected in
lymphoid tissues when infectious virus was undetectable
(Jones and Chowdhury, 2007). However, LR-RNA is not
extensively expressed in those tissues (Winkler et al.,
2000).
Upon reactivation, bICP0 expression is stimulated,
likely due to host entities (E2F family members) acting
on early promoters (Workman and Jones, 2010). LR
and ORF-E expression drop, and expression of other
(lytic) genes is readily detected (Jones and Chowdhury,
2007). Dexamethasone treatment can trigger reactivation.
It stimulates expression of cellular transcription factor
C/EBP-a (described above), which interacts with the
early promoter of bICP0 (Workman and Jones, 2010).
Upon reactivation, aHV can spread from the infected
neuron to adjacent cells at the axon synapse and along
the axon’s length (Tomishima and Enquist, 2002).
2.6. Transmission from the host
Virus is excreted from the host for 7–10 days after
infection (Jones and Chowdhury, 2007), with some
reports of 10–17 days with 1010 TCID50 (Straub, 1990).
Nose-to-nose contact, aerosol, breeding contact with
infected prepuce or vaginal epithelium, artificial insemi-
nation with infected semen, and even mechanical
transmission by ticks has been reported (Straub, 1990).
2.7. Consequences of infection
Diseases caused by BHV-1 include infectious bovine
rhinotracheitis (IBR) (McKercher et al., 1955), conjuncti-
vitis (McKercher et al., 1959), infectious pustular vulvo-
vaginitis (Kendrick et al., 1958), infectious pustular
balanoposthitis (Huck et al., 1971), and abortion (Orms-
bee, 1963) in adult cattle, as well as encephalitis (French,
1962a, 1962b), enteritis (Gratzek et al., 1966), and
generalized disease (Van Kruiningen and Bartholomew,
1964) in calves.
BHV-1 is also a significant initiator of and contributor
to ‘shipping fever’ pneumonia (Yates, 1982; Hodgins
et al., 2002; Ellis, 2009), a fibrinous pneumonia caused
by bacterial infection that is usually with Mannheimia
haemolytica and less commonly Pasteurella multocida or
others, subsequent to viral infection combined with
other factors. BHV-1 infection does this by increasing
susceptibility to secondary bacterial infection of the
lower respiratory tract through injury to and induction
of other changes in the tract and its cells, as well as
through the local and more generalized immunosuppres-
sion described in later sections and elsewhere (Yates,
1982; McChesney and Oldstone, 1987; Tikoo et al., 1995;
Babiuk et al., 1996; Hodgins et al., 2002; Ellis, 2009;
Levings and Roth, 2013).
The BRDC that includes BHV-1 respiratory disease and
shipping fever is the leading cause of cattle death loss in
the USA (Anon, 2011a), and has been estimated to cost
the US cattle industry US$3 billion annually (Jones and
Chowdhury, 2007). The cost of BHV-1 and associated
disease has resulted in extensive vaccination in North
America, and to eradication campaigns in some European
countries, including an expensive national program in
Switzerland using a (serology) test-and-remove strategy
(van Drunen Littel-van den Hurk, 2006).
3. The bovine innate immune response to BHV-1
3.1. The mammalian and bovine responses to
alphaherpesvirus infections
The most studied mammalian immune systems are those
of mice and humans. Aspects have been studied in other
species due to zoonotic diseases, the species’ economic
importance, as disease models, or to discern origins or
commonalities. Some features appear to be fundamental
and are conserved among vertebrates, jawed vertebrates,
or mammals (Hirano et al., 2011), allowing useful
generalizations or extrapolations. However, there are
also differences in strategies, component members,
sequences and so possibly modes of action [e.g. of
interleukins (IL)] between mammalian orders, families,
genera, and species.
It has been noted that ‘Cattle specific evolutionary
breakpoint regions have a higher density of species-
specific variations in genes having to do with lactation
and immune responsiveness’ (Bovine Genome Sequen-
cing and Analysis Consortium et al., 2009). Investigations
of bovine-specific immune phenomena have been
hampered by a lack of reagents (Rouse and Babiuk,
1978; Boysen et al., 2006), which is being addressed by
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the US Veterinary Immune Reagent Network and the
European ‘Immunological Toolbox’ (Entrican et al.,
2009). The interactions of stress, nutrition, and fertility
with the innate and adaptive immune systems are
important for cattle (Lippolis, 2008). The innate immune
system (particularly phagocytic cell function), is suscep-
tible to stress and nutrition impacts in cattle (Roth and
Perino, 1998), and stress including social factors may
impact their adaptive immune system (Salak-Johnson and
McGlone, 2007).
Most of what is known about immunity to aHV was
first elucidated in the HHV-1-mouse system, and then
confirmed or expanded in HHV-1/2-human and other
systems, e.g. SHV1-mouse or -swine. Studies of beta- and
gamma-HV (bHV and gHV) have also been instructive,
but revealed differences in viral strategies, e.g. gHV
employ more molecular mimicry than do aHV (Pellett
and Roizman, 2007).
In most cases, cattle are able to overcome a primary
BHV-1 infection, so the primary immune response
provides valuable information for primary, secondary,
and passive immunity. The subject has been well
reviewed at intervals (Rouse and Babiuk, 1978; Wyler
et al., 1989; Tikoo et al., 1995; Babiuk et al., 1996; Engels
and Ackermann, 1996; Muylkens et al., 2007). Briefly,
the first insult results in interaction with non-specific
soluble factors (constitutive and induced), which recruit
innate immune cells to the site and activate them. These
immune cells secrete more cytokines, kill virus-infected
cells, and bridge to the adaptive response, including by
presenting antigen (Ag) to LCs. Helper T cells then
activate macrophages (Mf) and natural killer (NK) cells,
and promote the proliferation of specific cytotoxic
T lymphocytes (CTLs). Later, peaking after the infection
is largely resolved, virus-neutralizing (VN) and other
antibodies (Abs) are detectable. They likely help with
clearing extracellular virus and with cellular cytotoxicity,
and then can protect the host from reinfection.
The bovine innate immune response to BHV-1 is
the focus of the remainder of this review. The bovine
adaptive immune response to the virus and vaccination to
prevent the diseases BHV-1 causes are the subjects of
another review (Levings and Roth, 2013).
3.2. Non-immune barriers
The organism can protect itself from infection
through avoidance of infected cohorts or materials
(Medzhitov et al., 2012). Mucous secretion and ciliary
action of epithelia, coughing, and sneezing, antimicrobial
substances in the air surface liquid, enzymes in tears
and saliva, and tight junctions between epithelial cells
protect the host from infection (Roth and Perino, 1998;
Ackermann et al., 2010; Keele and Estes, 2011). The host
must also have the correct receptors to be infected by
a virus; e.g. humans beings are not infected by many
non-human animal or plant viruses (Mayer, 2011). Once
infected or colonized, the host may tolerate the foreign
organism (Medzhitov et al., 2012). Non-specific com-
ponents of inflammation such as fever and the low pH
of infiltrates may hamper viral infection (Mayer, 2011).
Intracellular repression, e.g. cellular silencing of transcrip-
tion (Roizman et al., 2005) and stress-induced shutdown
of translation (Buchkovich et al., 2008), are additional,
non-immune responses to infection.
3.3. Innate immune system components and
activities
The first response to viral infection involves the innate
immune system, which is able to recognize and resist or
kill foreign organisms. Should the infection continue,
the innate response will have primed the more powerful
adaptive response (Iwasaki and Medzhitov, 2010;
Shetnten and Medzhitov, 2011), which in turn uses many
of the tools in the innate system. Innate and adaptive
immune cells have a complex interaction in aHV
infections (Schuster et al., 2011).
3.3.1. Infected cells
Infection of non-immune (e.g. mucosal epithelial) cells
triggers molecular signals for the infected and neighbor-
ing cells, including antimicrobial peptides (Klotman and
Chang, 2006; Ackermann et al., 2010) and interferons
(IFNs). Many of the same triggers and signals are used in
innate immune cells. Pathogens express signature mole-
cules, known as pathogen-associated molecular patterns
(PAMPs), essential to their survival and pathogenicity
(Kawai and Akira, 2006; Meylan and Tschopp, 2006;
Kumar et al., 2011). These are recognized by conserved,
germline-encoded host sensors known as pathogen
recognition receptors (PRRs). Several families of PRRs are
known to play a role in host defense, including toll-like
receptors (TLRs), retinoic acid-inducible gene I (RIG-I)-
like receptors (RLRs), nucleotide-binding oligomerization
domain (NOD)-like receptors (NLRs), and cytosolic DNA
receptors (Ackermann et al., 2010; Kumar et al., 2011).
Danger-associated molecular patterns (DAMPs) are gener-
ated by injured or dying cells or are present in the
extracellular matrix, and can modulate the activation of
PRRs (Tolle and Standiford, 2013).
The distribution of TLRs that recognize the PAMPs of
herpesviruses varies by cell type and by species (Carty
and Bowie, 2010; Paludan et al., 2011). Ten bovine TLRs
have been identified with specific but overlapping
PAMP specificities (Ackermann et al., 2010). Bovine TLR
sequences reveal 66–86% nucleotide or amino acid (aa)
sequence identity with their human/murine homologs
(Werling et al., 2006). Natural TLR variants enhance the
risk of severe infections in cattle (Seabury et al., 2010).
Four TLRs (2/6 heterodimer, 3, and 9) have been shown
to play a role in HSV resistance in mice. They act through
Innate immunity to bovine herpesvirus 1 93
MyD88 (Chew et al., 2009). TLR2 in association with TLR1
(Paludan et al., 2011) or TLR6 (Chew et al., 2009)
recognizes GPs upon attachment. Once the capsid is
internalized, viral dsDNA is recognized by TLR9 in the
endosome. When the viral DNA is transcribed, higher
order (ds, stem-loop) RNA molecules are recognized by
TLR3 (Paludan et al., 2011). When activated, the TLRs
induce different signaling cascades depending on the
adaptor protein, ultimately leading to the activation of the
transcription factors NF-kB, AP-1, and IFN-regulatory
factor (IRF)-3 (Martinon et al., 2009). HHV-1 infection
results in MyD88-dependent and TRIF-dependent signal-
ing (Vandevenne et al., 2010). TLR activation results in
the production of antimicrobial peptides, inflammatory
cytokines and chemokines, tumor necrosis factor
(TNF)-a , and costimulatory and adhesion molecules, as
well as in the up-regulation of major histocompatibility
complexes (MHCs) (Martinon et al., 2009).
The RLR family includes two RNA helicases, RIG-I and
melanoma differentiation associated gene-5 (MDA5),
which were identified as cytoplasmic, viral RNA sensors
(Martinon et al., 2009). The higher-order RNA molecules
produced after HV transcription are also recognized
by RIG-I (products of RNA polymerase III) or MDA5
(replication intermediates) in the cytoplasm (Paludan
et al., 2011). Upon viral stimulation of the two RLRs,
NF-kB and IRF3/7 are activated and, in turn, induce the
transcription of type I IFN (Ackermann et al., 2010).
NLRs are categorized in subfamilies and variably
distributed on innate immune cells and epithelia. HHV-1
is believed to trigger NALP3 (Chew et al., 2009). NLRs
stimulate cell activation, signaling through caspases
(Martinon et al., 2009). In the Mf inflammasome,
caspase-1 activation results in cleavage of pro-IL 1b to
active IL-1b and active IL-18 (Ackermann et al., 2010).
HHV-1 viral dsDNA is recognized in the cytoplasm by
DNA-dependent activator of IFN-regulatory factors (DAI)
(Paludan et al., 2011). This results in induction of type I
IFN and other genes involved in innate immunity
(Takaoka et al., 2007).
3.3.2. Type I IFNs
The IFN family of cytokines is grouped into types I,
II, and III. There are five human type I IFNs: IFN-a
(13 subtypes), -b ; -e; -k ; and -w . There is one type II IFN
(IFN-g ), and three type III (lambda) IFNs (IFN-l1–3 or
IL-28A/B and IL-29). Type I and III IFNs are expressed in
many cell types but type II is expressed in NK and T cells
(Paladino and Mossman, 2009).
Bovine IFN-a class 1 (10–12 members) and class 2
(15–20 members) each show greater sequence homology
with their human homologs than with the other bovine
class (Ohmann et al., 1987). Five bovine IFN-b genes
were identified, unlike the one in humans. The bovine
IFN-g is encoded by one gene with introns, similar to
other species (Ohmann et al., 1987). A bovine type III IFN
(bovine IFN-l3) was identified and characterized, includ-
ing characterization of its anti-viral activity (Segundo
et al., 2011). The receptor for IFN-l (IL-28Ra) is
expressed by a limited range of cells, but includes
epithelium, so mucosal epithelium can respond to IFN-l
(Perez-Martin et al., 2012).
IFN-a or -b binds Jak/Stat receptors on adjacent cells,
resulting in expression of a variety of anti-viral factors,
with activities from virus-binding to replication inhibition
(Ackermann et al., 2010). Type I IFNs induce resistance
to viral infection, increase MHC I expression and Ag
presentation, activate dendritic cells (DC) and Mfs, and
activate NK cells to kill virus-infected cells (Murphy et al.,
2008). IFN-b signals result in production of IFN-a
subspecies and other IFN-stimulated genes (ISG) includ-
ing IRF-7. IRF-7 activation results in up-regulation of IFN
type I and in a full range of ISG. IFN-l stimulation has
much the same effect, but in a more limited set of cells
(Perez-Martin et al., 2012).
In BHV-1 infection, type I IFN is present within 5 h
post-infection (Babiuk et al., 1996). It is induced in the
infected cell and in cells recruited to the site, and reaches
peak levels in nasal secretions and blood by 36–72 h post-
infection. Type I IFN levels remain elevated until virus
replication ceases (Babiuk et al., 1996). IFN-a regulates
polymorphonuclear neutrophil (PMN), NK, and Mf
effector activities and influences T-cell trafficking (Tikoo
et al., 1995). Locally induced IFN after aerosol BHV-1
infection was reported as providing partial protection
from a second infection with BHV-1 or other viruses
(Cummins and Rosenquist, 1980, 1982; MacLachlan and
Rosenquist, 1982; Ohmann et al., 1987). Intranasal (IN)
and intramuscular (IM) treatment with recombinant
bovine IFN-a1 reduced clinical signs but not virus
shedding of BHV-1 (Babiuk et al., 1987). Correlation of
IFN genotype and clinical outcome of BHV-1 infections
has been demonstrated (Ryan and Womack, 1997).
Six proteins encoded by HHV-1 inhibit IFN expression
or action: ICP0; ICP27; ICP34.5; US11; vhx; and US3
(Paladino and Mossman, 2009). HHV-1 ICP0 blocks IRF-3
and prevents IFN-b transcription. BHV-1 ICP0 inhibits
IFN-dependent transcription (Henderson et al., 2005) by
reducing IRF-3 protein levels, likely through degradation
(Saira et al., 2007). This leads to reduced IFN-b promoter
activity. In addition, bICP0 inhibits the ability of IRF-7
to activate IFN-b promoter activity, but does not reduce
IRF-7 protein levels (Jones and Chowdhury, 2007;
Jones, 2009).
3.3.3. IL and TNF-a
Bovine IL and TNF-a homologous to human and murine
members have been described, with varying degrees of
sequence similarity. These include: IL-1a and 1b
(Maliszewski et al., 1988); IL-2 (Cerretti et al., 1986), IL-
6 (Droogmans et al., 1992), IL-7 (Cludts et al., 1992), IL-10
(Hash et al., 1994), IL-12 (Zarlenga et al., 1995), IL-18
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(Shoda et al., 1999), and TNF-a (Cludts et al., 1993). Their
functions appear to be similar to the human/murine
homologs, as measured by response to similar stimuli
(White et al., 2002). The major pro-inflammatory cyto-
kines that are responsible for early responses are IL-1a ,
IL-1b , IL-6, and TNF-a . The balance of these with anti-
inflammatory cytokines (for example IL-4, IL-10) deter-
mines the status of the inflammation.
In BHV-1 infection, pro-inflammatory cytokines,
produced by infected cells and Mfs, cause an influx of
PMNs and induce ICAM-1 on epithelial cells, to which
leukocytes adhere. With increased vascular permeability,
immune cells migrate to the site of infection. IL-1 and IL-6
stimulate GM-CSF production, contribute to Mf differ-
entiation, and prime Mfs to release other molecules such
as TNF-a (Babiuk et al., 1996). IL-2 supports the growth
and differentiation of Ag-activated T cells. IL-1b and IL-2
have each been shown to enhance anti-BHV-1 responses
when administered to infected calves (Turin et al.,
1999).
3.3.4. Chemokines
Chemokines are a family of low molecular weight
chemoattractant cytokines. Chemokine expression may
result in monocyte or LC homing to the site of infection,
where the cells can differentiate or be activated. Bovine
chemokines and chemokine receptors (homologs to
human members) have been identified and similarities
but also differences noted (Son and Roby, 2006; Widdison
et al., 2010; Widdison and Coffey, 2011). BHV-1 gG is a
chemokine-binding protein, blocking activity (Bryant
et al., 2003) and preventing LC homing (Jones and
Chowdhury, 2007).
3.3.5. Complement
The complement (C) system is well conserved across
vertebrates (Zhu et al., 2005), although the bovine C5a
receptor has differences from human or murine homologs
(Nemali et al., 2008). The C cascade can be activated
by three pathways: alternate (spontaneous), lectin, and
classical (Ab). The latter is discussed elsewhere (Levings
and Roth, 2013). C can neutralize virus particles either by
direct lysis or by preventing viral penetration of host cells.
HHV-1-infected cells are killed by direct C lysis (Ohmann
and Babiuk, 1988). BHV-1 infected cells were killed by
C-dependent neutrophil-mediated cytotoxicity (CDNC)
(Ohmann and Babiuk, 1988).
Cells infected with BHV-1 (and HHV-1) express gC on
the cell surface, which can function as a receptor for
the cleavage product C3b (Ohmann and Babiuk, 1988;
Favoreel et al., 2003). It has been proposed that CDNC is
due to cross-linking of C3b between the viral gC on the
virus-infected cell and the receptor on the PMN (Babiuk
et al., 1996). The C3b receptor has also been proposed
to prevent C action on the virus or the infected cell
(Muylkens et al., 2007). In addition, it has been suggested
SHV1 incorporates host C regulators in its viral envelope
to regulate the spontaneous activation of the alternate
pathway (Favoreel et al., 2003).
3.3.6. Macrophages, neutrophils, and plasmacytoid
dendritic cells (pDC)
Innate immune system cells include phagocytic and other
cells that express PRRs that can recognize PAMPs. They
do not have memory, but can be primed in some cases.
Included in this category are the Mf, PMN, and DC.
Mfs have TLRs, scavenger receptors, and other PRRs on
their surfaces, and engulf extracellular pathogens. They
are important in BHV-1 infection, as shown by transfer
experiments (Rouse and Babiuk, 1977). Early in the
infection (after 3–4 days) they are a primary contributor of
IFN-a production, believed to be important in limiting
viral spread (Tikoo et al., 1995). Later they are stimulated
by IFN-g from T cells to kill virus-infected cells in a non-
MHC restricted way (Campos et al., 1989, Babiuk et al.,
1996). The activity is detectable as early as 2 days after
infection in lung parenchymal cells and 5–7 days after
infection in peripheral blood (Tikoo et al., 1995). BHV-1
infects Mfs, interfering with functions (Roth and Perino,
1998) such as TNF and other cytokine production, and
with participation in antibody-dependent cell-mediated
cytotoxicity (ADCC) (Tikoo et al., 1995). BHV-1 infection
of peripheral blood mononuclear cells (PBMCs) leads to
their apoptosis (Muylkens et al., 2007). Epitopes on gC
are similar to that of a Mf receptor, suggesting immune
evasion through molecular mimicry (Fitzpatrick et al.,
1990).
Neutrophils have PRR and receptors for C, and are the
principal cells engulfing pathogens (Murphy et al., 2008).
Bovine PMNs are the principal source of a-defensins, and
also produce (with epithelial cells) b-defensins and
cathelicidins (Ackermann et al., 2010). It was observed
that PMNs prevented BHV-1 plaque growth without
Ab, in a way that did not require contact (Rouse and
Babiuk, 1977). PMNs were the most effective cells in
ADCC assays, destroying infected cells more quickly
and completely, with less antiserum (Grewal et al., 1977).
BHV-1 interferes with lung PMN activities (Roth and
Perino, 1998; Muylkens et al., 2007), and PMN from BHV-
1-infected animals had reduced anti-bacterial functions
such as reduced chemotactic and phagocytic capacity
(Tikoo et al., 1995). Epitopes on gC also cross-react
with epitopes on PMNs, again suggesting immune evasion
through molecular mimicry (Fitzpatrick et al., 1990).
pDC express TLR7 and TLR9 in endosomes, with which
they sense viral nucleic acids (Gilliet et al., 2008). They
internalize Ag, including by means of Fcg IIa (Lanzavec-
chia and Sallusto, 2007), and rapidly produce large
amounts of type I IFNs when stimulated (Barchet et al.,
2005). pDC produce 1000 times the type I IFN of other
cells, can produce TNF-a and (in mice) IL-12
when stimulated, and can present Ag. So they are key
bridges from the innate immune response to the adaptive
one (Reizis et al., 2011). pDC have been identified in
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cattle – they generated high levels of type I IFN in
response to the TLR9 agonist CpG (Reid et al., 2011).
pDC have been described as the ‘professional producers’
of type I IFN in response to all human and mouse
HVs tested (Baranek et al., 2009). Although no reports of
bovine pDC response to BHV-1 have been published,
bovine pDC interacting with immune-complexed virus
were the major source of type I IFN production during
acute FMDV infection in cattle (Reid et al., 2011).
3.3.7. NK cells
NK cells are derived from a common lymphoid progenitor
with T cells and B cells, but have been categorized as
an innate immunity cell. They mediate cytotoxicity
as CTLs do (by degranulation), but the killing is not
MHC-restricted. Cytotoxic granules are released onto the
surface of the bound target cell, and the granule contents
(perforin and granzymes) penetrate the cell membrane
and induce programmed cell death. NK cells have
multiple receptor types: killer lectin-like receptors (KLRs);
killer cell immunoglobulin (Ig) -like receptors (KIRs);
and natural cytotoxicity receptors (NCRs) (Murphy et al.,
2008). NK cells can undergo a clonal-like expansion
following virus infection in human beings and mice,
and previously primed NK cells can mediate secondary
memory responses in mice in spite of lacking recombi-
nase activating gene (RAG)-recombinase-dependent
clonal Ag receptors (Paust and von Andrian, 2011; Sun
et al., 2011).
Bovine NK cells have been identified as constitutively
expressing homologs of the human NK receptors NKp46,
CD244, and CD94, and the granule proteins granulysin
and perforin (Endsley et al., 2006). Multiple receptors
have been identified on NKp46 (CD335) expressing,
CD3 LCs, including multiple KIRs and a single Ly49
(Boysen and Storset, 2009). NK cells produce IFN-g
(Boysen and Storset, 2009). Two sub-populations (CD2+
and CD2) were distinguished, both cytotoxic, both
producing IFN-g and transcripts for KIR, CD16, CD94,
and KLRJ (Boysen et al., 2006).
NK-like cells (CD2+, CD4, and CD8) were stimulated
by cytokines to kill BHV-1-infected cells without MHC
restriction (Babiuk et al., 1996). NK killing was dependent
on Ag expression, with gB and gD being primary targets
and gC of lower importance (Babiuk et al., 1996). NK cells
scan host cells for both stimulatory and inhibitory signals.
The reduction in MHC production that many cause aHV
should increase NK targeting. Some HV target both signals
for reduction using miRNAs, but this activity is not among
those listed for aHV when summarized by Griffin et al.
(2010). Some aHV-infected cells do internalize gB, which
should reduce NK targeting (Deruelle and Favoreel,
2011). Blocking of host cell apoptosis by BHV-1 and
other aHVs is described elsewhere (i.e. CTL section
Levings and Roth, 2013).
3.3.8. Interferon gamma
IFN-g is produced predominantly by NK and natural
killer T (NK T) cells as part of the innate immune
response, and by CD4+T-helper 1 (Th1) and CD8+ CTL
effector T cells as part of the adaptive immune response
(Schoenborn and Wilson, 2007). IL-12 produced by
Ag-presenting cells (APC) stimulates NK and T cells to
produce IFN-g (Jaime-Ramirez et al., 2011). The bovine
IFN-g is encoded similarly to other species (Ohmann
et al., 1987).
Type II IFN is involved in the immune response to
HHV-1 (Paladino and Mossman, 2009). It is ‘a predomi-
nant response after BHV-1 infection’ (Campos et al., 1989)
and is necessary for the activation of non-MHC restricted
cytotoxic activities mediated by Mfs. HHV-1 US3 modifies
the IFN-g receptor post-transcriptionally, resulting in
inhibition of ISG induction (Paladino and Mossman,
2009).
3.4. Innate-like intermediates
Four innate-adaptive evolutionary intermediates have
been described for human beings and mice: g d T cells,
B-1 cells, NK T cells, and natural Abs (Murphy et al.,
2008).
Human and murine T cells expressing ab and g d
TCRs are said to perform non-overlapping roles in the
immune response. ab T cells are located primarily
in secondary lymphoid organs, recognize peptides in
association with MHC I and II, and respond by facilitating
the production of Ab or by lysing infected target cells.
g d T cells represent a small percent of cells in the
thymus and secondary lymph tissue, are abundant at
epithelial surfaces and use fewer gene segments (to
encode the TCR) to recognize a wider variety of Ags,
including non-classical MHCs, heat shock proteins,
and lipids (Lee et al., 2010). Some g d T cells appear to
recognize Ag without presentation (Murphy et al., 2008).
Bovine g d T cells have different characteristics (Levings
and Roth, 2013).
B-1 cells are a separate lineage of B cells (distinct
from conventional, or B-2 cells) that produce large
quantities of multi-reactive IgM, IgG3 and IgA (natural
Ab) (Tarakhovsky, 1997; Hardy, 1992). Such CD5+ cells
are found in various proportions and locations by species,
and CD5 expression in cattle may represent activation
(Haas and Estes, 2001). Naessens (1997) suggested all
bovine B cells are of the B-1 lineage because they
lack IgD.
NK T cells express TCRs using one invariant a chain,
paired with one of a few b chains, and they produce
cytokines rapidly (Murphy et al., 2008). It has been
posited that cattle don’t have NK T cells based on their
lack of a functional CD1d gene and a failure to react to a
potent NK T stimulus (Van Rhijn et al., 2006).
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4. Summary/conclusions
BHV-1 is an aHV infecting a variety of artiodactyl
species. Its 135,301 bp genome includes 73 genes, whose
transcription is temporally regulated. The 12 envelope
proteins include five GP involved in viral attachment and
entry. Infection results in both rapid lytic replication and
latent infection, primarily in sensory ganglia.
The infected cell recognizes the pathogen’s compo-
nents and replicative intermediates by means of a variety
of PRRs, and responds using internal signals and signaling
of other cells via IL to express anti-viral factors. Pro-
inflammatory cytokines produced by infected cells and
Mf result in recruitment and activation of innate immune
cells. These cells, including Mfs, PMNs, pDCs, and NK
cells, use similar PRRs and signals, phagocytose the
pathogen or kill infected cells, and if insufficient to clear
the infection, prime and bridge to the adapative immune
response.
The virus possesses a variety of immune evasion
strategies, including: inhibition of type I IFN production
by multiple mechanisms; binding of chemokines and C
cleavage products; infection of Mfs and PMNs resulting
in reduced function; immune evasion via molecular
mimicry; and latent infection with decrease of structural
gene expression. In summary, there is a delicate balance
between viral infection, host response, and viral evasive
measures in BHV-1 infection and immunity in cattle.
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